John De Grandpre

John directs the legal strategy and compliance programs that enable the company’s growth initiatives while mitigating risk. Previously, John served as General Counsel & Chief Compliance Officer for Capsugel, a company acquired from Pfizer by a private equity sponsor for $2.4 billion and later sold for $5.5 billion. Prior to that, John worked at Pfizer, with legal responsibilities across Consumer Healthcare, Global Manufacturing, and the Capsugel business, and at two law firms where he specialized in M&A and capital markets transactions. John holds an A.B. from Georgetown University and a J.D. from the University of Virginia School of Law.